Skip To Main Content
ICMUB Laboratory on Muck Rack

ICMUB Laboratory

As seen in: Oxford Academic, EJNMMI Research
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with ICMUB

Contact ICMUB, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Answer: Have the remnographic eye: a rare cause of pericardial effusion after myocardial infarction

|
By ICMUB Laboratory
| Oxford Academic Verified
This Spot the Diagnosis article refers to ‘Question: Have the remnographic eye: a rare cause of pericardial effusion after myocardial infarction’, by A. Braillon et al. https://doi.org/10.1093/ehjacc/zuae127. A 70-year-old woman with no relevant past medical history, active smoker, and treated for a dyslipidaemia, presented with chest pain from the day before.
Open in Who Shared Issue with article?

Embolic Effect of Different Cyanoacrylates: Radiological and Histological Comparison in an In Vivo Rabbit Renal-Artery Model - CardioVascular and Interventional Radiology

|
By ICMUB Laboratory, Université de Bourgogne, Guerbet Research, Serge Ludwig
| link.springer.com
Abstract To compare the radiological and histological effects of three different cyanoacrylate glues used for in vivo renal artery embolization in rabbits. N-butyl cyanoacrylate (NBCA), NBCA-methacryloxysulfolane (NBCA-MS), and α-hexyl-cyanoacrylate (AHCA) were each used to embolize five renal arteries under free-flow conditions with a 1:3 glue/ethiodized oil ratio. The rabbits were euthanized 30 min after embolization.
Open in Who Shared Issue with article?

Respective contribution of baseline clinical data, tumour metabolism and tumour blood-flow in predicting pCR after neoadjuvant chemotherapy in HER2 and Triple Negative breast cancer | EJNMMI Research | Full Text

|
By ICMUB Laboratory
| EJNMMI Research Verified
The present cohort of patients has already been described in detail in previous publications from our institution [23]. To summarise, a total of 217 patients with newly diagnosed stage II or III breast cancer and with an indication for NAC were prospectively considered for participation to this study. Based on oncologists’ recommendations, these patients were recruited from July 2011 to May 2017 for a 18F-Fluorodeoxyglucose (FDG) PET/CT scan before treatment.
Open in Who Shared Issue with article?
See all 4 articles